https://www.healio.com/news/infectious-disease/20231014/rsv-vaccine-remains-effective-across-two-seasons-study-shows
BOSTON — GSK’s respiratory syncytial virus vaccine had a sustained effectiveness of around 67% among adults aged 60 years or older across two full RSV seasons, researchers reported at IDWeek.
Create an account or login to join the discussion